Objective Cytoreduction for ovarian cancer is definitely associated with considerable morbidity. in those who did NVP-BKM120 Hydrochloride not require any prolonged methods to 12.9% after 1 procedure 28.4% for those who experienced 2 and 30.0% in women who underwent ≥3 extended methods (P